Table 1: Patient and tumor characteristics.

Age at time of treatment (years)
 Median56
 Range12–85
Patients ( )
 Male7 (44%)
 Female9 (56%)
Lesions ( )
 Peripheral19 (76%)
 Central6 (24%)
Histology
 Leiomyosarcoma7
 Synovial cell5
 Osteosarcoma4
 Liposarcoma2
 NOS2
 Spindle cell1
 Chondrosarcoma1
 Liposarcoma1
 Hemangiopericytoma1
 Embryonal 1
Dose fractionation and BED*
 54 Gy, 3 fractions (BED = 151.2 Gy)13 (52%)
 50 Gy, 4 fractions (BED = 112.5 Gy)9 (36%)
 36 Gy, 3 fractions (BED = 79.2 Gy)2 (8%)
 42 Gy, 3 fractions (BED = 100.8 Gy)1 (4%)

Biological equivalent dose is calculated per (1), assuming / ratio of 10 for tumor (   = number of fractions, = total dose).